Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 2
1986 3
1987 1
1988 1
1989 2
1990 3
1991 2
1992 5
1993 3
1994 2
1995 6
1996 4
1997 7
1998 2
1999 2
2000 6
2001 3
2002 6
2003 8
2004 5
2005 3
2006 4
2007 5
2008 7
2009 6
2010 8
2011 6
2012 7
2013 4
2014 6
2015 4
2016 5
2017 4
2018 1
2019 1
2020 3
2021 3
2022 7
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma.
Houles T, Lavoie G, Nourreddine S, Cheung W, Vaillancourt-Jean É, Guérin CM, Bouttier M, Grondin B, Lin S, Saba-El-Leil MK, Angers S, Meloche S, Roux PP. Houles T, et al. Among authors: meloche s. Nat Commun. 2022 Oct 29;13(1):6457. doi: 10.1038/s41467-022-34179-8. Nat Commun. 2022. PMID: 36309522 Free PMC article.
A renaissance for YES in cancer.
Lapouge M, Meloche S. Lapouge M, et al. Among authors: meloche s. Oncogene. 2023 Nov;42(46):3385-3393. doi: 10.1038/s41388-023-02860-x. Epub 2023 Oct 17. Oncogene. 2023. PMID: 37848624 Review.
Redundancy in the World of MAP Kinases: All for One.
Saba-El-Leil MK, Frémin C, Meloche S. Saba-El-Leil MK, et al. Among authors: meloche s. Front Cell Dev Biol. 2016 Jun 27;4:67. doi: 10.3389/fcell.2016.00067. eCollection 2016. Front Cell Dev Biol. 2016. PMID: 27446918 Free PMC article. Review.
ERKs in cancer: friends or foes?
Deschênes-Simard X, Kottakis F, Meloche S, Ferbeyre G. Deschênes-Simard X, et al. Among authors: meloche s. Cancer Res. 2014 Jan 15;74(2):412-9. doi: 10.1158/0008-5472.CAN-13-2381. Epub 2014 Jan 9. Cancer Res. 2014. PMID: 24408923 Review.
YES, a novel therapeutic target in hepatocellular carcinoma.
Lapouge M, Meloche S. Lapouge M, et al. Among authors: meloche s. Mol Cell Oncol. 2022 May 1;9(1):2069993. doi: 10.1080/23723556.2022.2069993. eCollection 2022. Mol Cell Oncol. 2022. PMID: 35529900 Free PMC article.
154 results